...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: To paraphrase…

 The question is, "Will we share in any winnings?" I don't think this current team is capable of much more than what we have seen so far. If either of these companies does succeed, it will probably be under a new management team installed by the major insiders, with the outgoing team handsomely rewarded for handing over the reins. basketball stars

Share
New Message
Please login to post a reply